Back to search
FDAFDA · Food and drugs·Recall number D-0600-2022

Children's Pain & Fever Acetaminophen, 160 mg per 5 mL Oral Suspension combo pack. DS SR APAP 160MG CHLD BBGM/DF CHRY/GRP. UPC: 3 70030 11637 9

Published March 2, 2022 · Recall initiated: October 26, 2021

Summary

FDA records drug Class II recall D-0600-2022, published March 2, 2022 and initiated October 26, 2021. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 561 bottles; Lot: Batch: 1EV1874, Exp 11/02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Perrigo Company PLC
Distributor
Nationwide in the USA
Lot
Batch: 1EV1874, Exp 11/02/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Children's Pain & Fever Acetaminophen, 160 mg per 5 mL Oral Suspension combo pack. DS SR APAP 160MG CHLD BBGM/DF CHRY/GRP. UPC: 3 70030 11637 9 recalled?

Yes. FDA published recall D-0600-2022 on March 2, 2022. Reported hazard: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What should I do if I have this product?

Voluntary: Firm initiated · Letter